By activating the Akt-eNOS signaling pathway, Compound Danshen injection can protect myocardial cells from MI/R injury, inhibit myocardial cell apoptosis, and further reduce the incidence of cardiac failure (Ren-an et al., 2014). This evidence concerns the gene AKT1 and myocardial infarction.